Difference between revisions of "Team:BIT/HP4"
| Line 84: | Line 84: | ||
<div class="row animate-box"> | <div class="row animate-box"> | ||
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | <div class="col-md-8 col-md-offset-2 text-center fh5co-heading"> | ||
| − | < | + | <h1>Integrated Human Practice</h1> |
</div> | </div> | ||
| Line 90: | Line 90: | ||
<div class="row animate-box"> | <div class="row animate-box"> | ||
<div class="col-md-6 col-md-offset-3 text-center heading-section"> | <div class="col-md-6 col-md-offset-3 text-center heading-section"> | ||
| − | < | + | <h2>What Can We Solve？</h2 |
<p>This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities. Biomarkers can reflect the user’s risk of corresponding cancer to.So as to warn the real patients to go to the hospital earlier.Less money,but higher cure rate.</p> | <p>This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities. Biomarkers can reflect the user’s risk of corresponding cancer to.So as to warn the real patients to go to the hospital earlier.Less money,but higher cure rate.</p> | ||
</div> | </div> | ||
| Line 103: | Line 103: | ||
<div class="row animate-box"> | <div class="row animate-box"> | ||
<div class="col-md-6 col-md-offset-3 text-center heading-section"> | <div class="col-md-6 col-md-offset-3 text-center heading-section"> | ||
| − | < | + | <h2>Where is our market？</h2> |
<p>Diagnostic Market”,so how about IVD? | <p>Diagnostic Market”,so how about IVD? | ||
JACOB falls in the category of in vitro diagnostic devices, particularly serum biomarker detection. Diagnosis market is characterized by inelastic demanding and steady growth. According to the International Trade Administration, medical device market is forecasted to grow $20 Billion per year after 2017, along with constant growth of population. For United States solely, In Vitro diagnostic devices made up 14.7% of total medical device export in 2015, while keep increasing, currently ranked 4th among all categories. Such market is advantageous to the commercialization of JACOB.</p> | JACOB falls in the category of in vitro diagnostic devices, particularly serum biomarker detection. Diagnosis market is characterized by inelastic demanding and steady growth. According to the International Trade Administration, medical device market is forecasted to grow $20 Billion per year after 2017, along with constant growth of population. For United States solely, In Vitro diagnostic devices made up 14.7% of total medical device export in 2015, while keep increasing, currently ranked 4th among all categories. Such market is advantageous to the commercialization of JACOB.</p> | ||
| Line 119: | Line 119: | ||
<div class="row animate-box"> | <div class="row animate-box"> | ||
<div class="col-md-6 col-md-offset-3 text-center heading-section"> | <div class="col-md-6 col-md-offset-3 text-center heading-section"> | ||
| − | < | + | <h2>What determined characteristics of JACOB?</h2> |
<p><center>We determined the main characteristics of JACOB gradually through three stages<center></p> | <p><center>We determined the main characteristics of JACOB gradually through three stages<center></p> | ||
</div> | </div> | ||
Revision as of 17:07, 30 October 2017
Integrated Human Practice
What Can We Solve？
This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities. Biomarkers can reflect the user’s risk of corresponding cancer to.So as to warn the real patients to go to the hospital earlier.Less money,but higher cure rate.Where is our market？
Diagnostic Market”,so how about IVD? JACOB falls in the category of in vitro diagnostic devices, particularly serum biomarker detection. Diagnosis market is characterized by inelastic demanding and steady growth. According to the International Trade Administration, medical device market is forecasted to grow $20 Billion per year after 2017, along with constant growth of population. For United States solely, In Vitro diagnostic devices made up 14.7% of total medical device export in 2015, while keep increasing, currently ranked 4th among all categories. Such market is advantageous to the commercialization of JACOB.
What determined characteristics of JACOB?
Hire Us!
Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.
